The Molecular Tumor Biology and Personalized Precision Therapy Lab, under the direction of Pascal Zinn, MD, PhD, focuses on patient-centered care for brain and spinal tumors. Every patient is unique and so is every tumor; therefore, a personalized precision approach is fundamental to the treatment of tumors.
Utilizing humanoid brain disease avatars or so-called brain organoid models, Dr. Zinn replicates the patient’s condition in the laboratory and thus studies how tumors form and how tumors can be treated using tumor genetics precision approaches.
Furthermore, Dr. Zinn is developing personalized biologically-adaptable and patient-tailored, virus-based therapies for brain cancer.